Silbert

Cassava | Tomorrow - scheduled end of phase IIb | Jackpot?

Silbert 업데이트됨   
NASDAQ:SAVA   Cassava Sciences, Inc.
Is SAVA about to blow up soon? The phase IIb will be most likely done by tomorrow whereby the analysis and evaluation of the results is scheduled for May. So there might be one last pullback before the stock will pulverize the last highs (in case the results are positive!). As a consequence of that I will look for good entries to ride the stock to at least 20$ per share :).
코멘트:
Launch successful :). The NIH is funding another $2.5 million, which might be a good sign for positive phase 2b results.
코멘트:
The results aren't published yet, but the expectations grow! The stock is rising sharply :)

면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.